Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma - Université de Bretagne Occidentale Access content directly
Journal Articles Nuclear Medicine and Biology Year : 2022

Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma

Cassandra Métivier
  • Function : Author
Patricia Le Saec
  • Function : Author
Hela Bouhsine
  • Function : Author
Séverine Marionneau-Lambot
  • Function : Author
Emmanuel Garçion
  • Function : Author
Ferid Haddad
  • Function : Author
Michel Chérel
  • Function : Author
Alain Faivre-Chauvet
  • Function : Author
Latifa Rbah-Vidal
  • Function : Author
No file

Dates and versions

hal-04545853 , version 1 (14-04-2024)

Identifiers

Cite

Cassandra Métivier, Patricia Le Saec, Hela Bouhsine, Séverine Marionneau-Lambot, Emmanuel Garçion, et al.. Development and in vitro evaluation of a copper-64 radiolabeled antibody for targeting the CXCR4 receptor in human multiple myeloma. Nuclear Medicine and Biology, 2022, 108-109, pp.S203-S204. ⟨10.1016/S0969-8051(22)00419-X⟩. ⟨hal-04545853⟩
8 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More